Advancements in deep learning for early diagnosis of Alzheimer's disease using multimodal neuroimaging: challenges and future directions.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Muhammad Khizar Abbas, Kinza Batool, Syed Tawassul Hassan, Noorulain Hyder, Subia Jamil, Muhammad Liaquat Raza, Sajidah Walji

Ngôn ngữ: eng

Ký hiệu phân loại: 616.926 *Escherichia coli infections

Thông tin xuất bản: Switzerland : Frontiers in neuroinformatics , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 747143

INTRODUCTION: Alzheimer's disease is a progressive neurodegenerative disorder challenging early diagnosis and treatment. Recent advancements in deep learning algorithms applied to multimodal brain imaging offer promising solutions for improving diagnostic accuracy and predicting disease progression. METHOD: This narrative review synthesizes current literature on deep learning applications in Alzheimer's disease diagnosis using multimodal neuroimaging. The review process involved a comprehensive search of relevant databases (PubMed, Embase, Google Scholar and ClinicalTrials.gov), selection of pertinent studies, and critical analysis of findings. We employed a best-evidence approach, prioritizing high-quality studies and identifying consistent patterns across the literature. RESULTS: Deep learning architectures, including convolutional neural networks, recurrent neural networks, and transformer-based models, have shown remarkable potential in analyzing multimodal neuroimaging data. These models can effectively process structural and functional imaging modalities, extracting relevant features and patterns associated with Alzheimer's pathology. Integration of multiple imaging modalities has demonstrated improved diagnostic accuracy compared to single-modality approaches. Deep learning models have also shown promise in predictive modeling, identifying potential biomarkers and forecasting disease progression. DISCUSSION: While deep learning approaches show great potential, several challenges remain. Data heterogeneity, small sample sizes, and limited generalizability across diverse populations are significant hurdles. The clinical translation of these models requires careful consideration of interpretability, transparency, and ethical implications. The future of AI in neurodiagnostics for Alzheimer's disease looks promising, with potential applications in personalized treatment strategies.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH